Literature DB >> 17532784

Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.

Chen-Chun Lin1, Chun-Jung Lin, Chao-Wei Hsu, Yi-Cheng Chen, Wei-Ting Chen, Shi-Ming Lin.   

Abstract

BACKGROUND: Distinguishing dysplasia from hepatocellular carcinoma (HCC) by fine-needle aspiration (FNA) cytology is difficult. The aim of this study was to diagnose HCC and the distinction of liver cell dysplasia from HCC with different grades by interpreting and scoring the cyto-morphological features.
METHODS: Eighty-three cirrhotic patients undertook a sonography-guided FNA and subsequent needle biopsy for the tumor. HCC was confirmed in 68 cases and cirrhosis with dysplasia in 15 cases by pathology and follow-up for longer than 2 years. Eighteen cytological features were scored as degree of one, two or three according to their presence or prominence.
RESULTS: Two cases of well-differentiated HCC were diagnosed as negative for HCC initially. The sensitivity, specificity, false positive, false negative and accuracy were 97%, 100%, 0%, 3% and 97.6% for FNA cytology in the diagnosis of HCC, respectively. The score of dysplasia was 20.8 +/- 1.3 (mean +/- SD) and lower than 26.2 +/- 3.4 in Edmondson's grade I HCC (P < 0.01), 28.9 +/- 2.9 in grade II HCC (P < 0.01), and 34.9 +/- 4.3 in grade III/IV HCC (P < 0.01). The score was also significantly lower in grade II HCC than in grade III/IV HCC (P < 0.01).
CONCLUSIONS: FNA yielded a high accuracy in the distinction of dysplasia from HCC with different grades. There is a good correlation in cyto-morphological scores of liver cell dysplasia and HCC with different grades. Dysplasia displayed the lowest score and the score increased in order from dysplasia to grade III/IV HCC.

Entities:  

Mesh:

Year:  2007        PMID: 17532784     DOI: 10.1111/j.1440-1746.2007.04924.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations.

Authors:  Aileen Wee
Journal:  Patholog Res Int       Date:  2011-06-30

2.  HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.

Authors:  Ming-Ling Chang; Shi-Ming Lin; Chau-Ting Yeh
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

3.  Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens.

Authors:  Sho Kitamura; Keita Kai; Mitsuo Nakamura; Tomokazu Tanaka; Takao Ide; Hirokazu Noshiro; Eisaburo Sueoka; Shinich Aishima
Journal:  Cancers (Basel)       Date:  2022-05-05       Impact factor: 6.639

4.  Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive Surgery.

Authors:  Tsung-Han Wu; Yu-Chao Wang; Hao-Chien Hung; Jin-Chiao Lee; Chia-Ying Wu; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan; Wei-Chen Lee
Journal:  J Pers Med       Date:  2022-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.